MRI Use Before Prostate Biopsies Rises Sharply in U.S. Hospitals

By Rachel Kim

The use of MRI before prostate biopsies has seen a substantial increase in U.S. hospitals, according to a recent study published in JAMA Oncology. The analysis, which reviewed 505,000 prostate biopsies from January 2017 to June 2026, found that the rate of pre-biopsy MRI utilization rose from 14% in 2017 to 64% in the first half of 2026.

This trend reflects a broader shift in clinical practice, with guidelines increasingly recommending MRI before biopsies to improve the detection of aggressive prostate cancers. The increase in MRI use is supported by major randomized trials, such as PROMIS and PRECISION, which have demonstrated that MRI-targeted biopsies can identify more clinically significant cancers while reducing unnecessary procedures.

The American Urological Association (AUA) and the European Association of Urology (EAU) have updated their guidelines to incorporate MRI into the diagnostic pathway. Despite these advancements, the study indicates that approximately one-third of men undergoing initial biopsies still do not receive a pre-biopsy MRI, highlighting a gap in care quality.